AP
CLOV icon

Anchyra Partners’s Clover Health Investments CLOV Stock Holding History

Anchyra Partners’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.8K Buy
+15,226
New +$51.7K 0.02% 342

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Anchyra Partners's CLOV Position: Q2 2026 in Review

Anchyra Partners opened a new position in Clover Health Investments (CLOV) in Q2 2026: 15,226 shares worth $79.8K. The stake represents 0.02% of the portfolio and ranks #342 among its holdings.

91 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Anchyra Partners held 15,226 shares of Clover Health Investments worth $79.8K as of Q2 2026.
  • Clover Health Investments was a new Anchyra Partners position in Q2 2026.
  • Clover Health Investments made up 0.02% of Anchyra Partners's portfolio in Q2 2026, its #342 holding.
  • 91 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.